|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls000767399 |
| 003 |
SK-MaSNL |
| 005 |
20260415103654.0 |
| 008 |
250429c2001 xo 0 slo |
| 015 |
|
|
|a SNBRB2001/10-27928
|
| 035 |
|
|
|a CLN000119186
|
| 035 |
|
|
|a urn:nbn:sk:snk-abd3wo
|
| 035 |
|
|
|a (urnnbn)urn:nbn:sk:snk:ar-007jwh
|
| 035 |
|
|
|a (uuid)c4d2905b-3724-429a-a87b-7e74e438b3f8
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a eng
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 615.272.4.015.2
|2 1997
|
| 100 |
1 |
|
|a Bellosta, S.
|4 aut
|9 1427822
|
| 245 |
1 |
0 |
|a Drug interactions in antiatherosclerotic therapy
|c S. Bellosta, A. Corsini
|
| 300 |
|
|
|b Tab.
|
| 504 |
|
|
|a Res. angl.
|
| 504 |
|
|
|a Bibliogr. odkazy
|
| 650 |
0 |
7 |
|a inhibítory hydroxymetylglutaryl-CoA-reduktázy
|x farmakológia
|x farmakokinetika
|2 snkbucl
|9 1427823
|
| 650 |
0 |
7 |
|a myopatia
|2 snkbucl
|9 2533
|
| 650 |
0 |
7 |
|a rabdomyolýza
|2 snkbucl
|9 848998
|
| 650 |
0 |
7 |
|a ateroskleróza
|2 snkbucl
|9 2428
|
| 650 |
0 |
7 |
|a hypercholesterolémia
|x farmakoterapia
|2 snkbucl
|9 855725
|
| 650 |
0 |
7 |
|a myopatia
|x chemicky indukované
|x epidemiológia
|2 snkbucl
|9 1427824
|
| 650 |
0 |
7 |
|a interakcie liekové
|2 snkbucl
|9 845134
|
| 650 |
0 |
7 |
|a inhibítory hydroxymetylglutaryl-CoA- reduktázy
|x farmakológia
|x farmakokinetika
|x terapeutické použitie
|2 snkbucl
|9 1427825
|
| 655 |
|
7 |
|a štúdie
|2 snkbucl
|9 57033
|
| 700 |
1 |
|
|a Corsini, A.
|4 aut
|9 1427826
|
| 773 |
0 |
|
|t Ateroskleróza
|g Roč. 5, č. 1 (2001), s. 4-7
|x 1335-2253
|
| 850 |
|
|
|a Slovenská národná knižnica
|
| 852 |
|
|
|a Slovenská národná knižnica
|
| 954 |
|
|
|a odborná, vedecká literatúra cudzojazyčná (svetová)
|2 lita
|
| 958 |
|
|
|a article17
|
| 958 |
|
|
|a NB
|
| 958 |
|
|
|a MI
|
| 958 |
|
|
|a OND
|
| 958 |
|
|
|a EUIPO
|
| 992 |
|
|
|a RBX
|
| 999 |
|
|
|c 2888009
|d 2889939
|
